Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Girard:2022:10.1016/j.annonc.2022.07.1159,
author = {Girard, N and Popat, S and Shoshkova, S and Fear, S and Perez, Gracia JL},
doi = {10.1016/j.annonc.2022.07.1159},
pages = {S1027--S1028},
publisher = {ELSEVIER},
title = {IMreal Cohort 2: Second interim analysis of efficacy and safety data in patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) under real-world conditions},
url = {http://dx.doi.org/10.1016/j.annonc.2022.07.1159},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Girard,N
AU - Popat,S
AU - Shoshkova,S
AU - Fear,S
AU - Perez,Gracia JL
DO - 10.1016/j.annonc.2022.07.1159
EP - 1028
PB - ELSEVIER
PY - 2022///
SN - 0923-7534
SP - 1027
TI - IMreal Cohort 2: Second interim analysis of efficacy and safety data in patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC) receiving atezolizumab (atezo) under real-world conditions
UR - http://dx.doi.org/10.1016/j.annonc.2022.07.1159
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866211601298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -